Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy

Satoru Noguchi*, Elizabeth M. McNally, Kamel Ben Othmane, Yasuko Hagiwara, Yuji Mizuno, Mikiharu Yoshida, Hideko Yamamoto, Carsten G. Bönnemann, Emanuela Gussoni, Peter H. Denton, Theodoros Kyriakides, Lefkos Middleton, Faycal Hentati, Mongi Ben Hamida, Ikuya Nonaka, Jeffery M. Vance, Louis M. Kunkel, Eijiro Ozawa

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

478 Scopus citations


Severe childhood autosomal recessive muscular dystrophy (SCARMD) is a progressive muscle-wasting disorder common in North Africa that segregates with microsatellite markers at chromosome 13q12. Here, it is shown that a mutation in the gene encoding the 35-kilodalton dystrophin-associated glycoprotein, γ-sarcoglycan, is likely to be the primary genetic defect in this disorder. The human γ-sarcoglycan gene was mapped to chromosome 13q12, and deletions that alter its reading frame were identified in three families and one of four sporadic cases of SCARMD. These mutations not only affect γ-sarcoglycan but also disrupt the integrity of the entire sarcoglycan complex.

Original languageEnglish (US)
Pages (from-to)819-822
Number of pages4
Issue number5237
StatePublished - 1995

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy'. Together they form a unique fingerprint.

Cite this